Research
/
Stock
/
ELV
E
ELV
Elevance Health, Inc.
FY2025
i
Mkt cap 88.0B
Financial
398.87
-3.76 -0.93%
close 2026-08-25
i
Overview
Financials
Insider
DCF
Research
/
Stock
/
…
Pulling SEC filings & building this page… the first lookup of a new ticker takes a few seconds, then it's cached.
Mkt Cap
i
88.0B
P/E
i
15.8
Revenue FY2025
i
199.1B
Gross Margin
i
89.4%
FCF FY2025
i
3.2B
Net Income
i
5.7B
52-week range
i
280.74
-6.5% off high
i
426.79
Beta
i
0.43
vs S&P 500 · 1232 common days
Dividend
i
1.74%
$1.5B paid in FY2025 · on today's cap
Price
i
1M
6M
1Y
5Y
i
i
Revenue
i
199.1B
FY2025
i
·
+12.5% YoY
i
i
EBITDA
i
—
n/a for banks / REITs
Free Cash Flow
i
3.2B
FY2025
i
·
-30.3% YoY
i
i
EPS (diluted)
i
25.21
FY2025
i
·
-1.8% YoY
i
i
Earnings
i
next est.
Last reported
15 Jul 2026 · 8-K (2.02)
Next report
≈ 9 Oct 2026
Moat & Risks
i
Engine pending
89.4% gross margin (FY2025) — pricing-power signal.
FY2025 10-K ›
Revenue +12.49% YoY to 199.1B (FY2025).
FY2025 10-K ›
Sourced moat / risk brief — generated by the Silkcodex engine (pending run).
Insider activity
i
11 Form 4 · 3 open-market buys vs 3 sells
i
All transactions →
+542K
net open-market
i
2026-07-17
P
Peru Ramiro G
· Director
Buy
1,000
366K
2026-07-17
P
Boudreaux Gail
· President and CEO
Buy
680
249K
2026-07-17
P
Boudreaux Gail
· President and CEO
Buy
2,045
753K
2026-06-12
S
Penczek Ronald W
· CAO & Controller
Sell
369
149K
2026-06-11
S
Dixon Robert L Jr
· Director
Sell
151
61K
Recent filings
8 on file · SEC EDGAR
i
2026-07-15
10-Q
Quarterly report
EDGAR ›
2026-07-15
8-K
Earnings results · Exhibits
EDGAR ›
2026-06-10
8-K
Reg FD disclosure
EDGAR ›
2026-05-13
8-K
Shareholder vote
EDGAR ›
2026-04-22
10-Q
Quarterly report
EDGAR ›